4.6 Article

The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Effectiveness and Safety of Bevacizumab for Unresectable Non-Small-Cell Lung Cancer A Meta-Analysis

Kun Yang et al.

CLINICAL DRUG INVESTIGATION (2010)

Article Medicine, General & Internal

Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.

Makoto Maemondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Oncology

Bevacizumab for the treatment of advanced non-small-cell lung cancer

Christian Manegold

EXPERT REVIEW OF ANTICANCER THERAPY (2008)

Article Health Care Sciences & Services

Evaluation of networks of randomized trials

Georgia Salanti et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2008)

Article Medicine, General & Internal

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Kathy Miller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Alan Sandler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Erlotinib in previously treated non-small-cell lung cancer

FA Shepherd et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)